Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: LOVELACE BIOMEDICAL RESEARCH INSTITUTE
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-29 to 2025-09-28
Current total value of award: $623883
Description: EFFICACY AND SAFETY EVALUATION OF A LEAD GENE THERAPY CANDIDATE IN METHYL MELANOMIC ACIDEMIA (MMAB) DISEASE MOUSE MODELS AND BIOANALYTICAL ASSAY METHODS DEVELOPMENT.